Expression of the human MAPT, hTau-A152T variant, is regulated by the tetracycline-responsive regulatory element (tetO) in these TRE-hTau-A152T line L1 mice. When mated with a strain expressing tetracycline-controlled transactivator protein (tTA), expression of the hTau-A152T protein may be regulated with the tetracycline analog doxycycline (dox) in the double-allelic offspring. This strain may be useful in studies related to frontotemporal dementia, Alzheimer’s disease, and other neurodegenerative diseases.
Lennart Mucke, Gladstone Inst of Neurological Disease
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Inducible, Inserted expressed sequence, Humanized sequence) |
Mice hemizygous for the hTau-A152T transgene, founder line line L1, are viable and fertile. Expression of the 1N4R isoform of human MAPT (microtubule associated protein tau) with an A152T substitution is regulated by a tetracycline operator (tetO); also called tetracycline-responsive element (TRE, TetRE) or tet-operator). When mated to a mutant strain expressing tetracycline-controlled transactivator protein (tTA), expression of mutant 1N4R isoform of human MAPT protein may be regulated with tetracycline or its analog doxycycline (dox) in the double mutant offspring. No human MAPT protein is detected in brain sections from singly transgenic mice by western blotting and immunohistochemical staining. When these line C11-1 hTau-A152T transgenic mice are crossed to CaMKII-tTA mice (see, for example, Stock No. 007004), the adult double mutant mice have a lower body weight than wildtype and single C11-1 hTau-A152T transgenic controls. Hemizygotes are viable and fertile. Homozygous viability/fertility has not been tested (June 2016).
A transgenic construct containing cDNA of the human MAPT gene encoding the 1N4R isoform, with upstream intronic sequence (from pCI-neo vector) and a Kozak sequence, and downstream bovine growth hormone polyadenylation sequence, all under the control of the tetO, tetracycline-responsive regulatory element (pTRE-Tight), was injected into fertilized C57BL/6 mouse eggs. Founder line C11-1, also known as founder line L1, was subsequently established. Upon arrival at The Jackson Laboratory, the mice were crossed to C57BL/6J (Stock No. 000664) to cryopreserve embryos. To establish our live colony, cryopreserved embryos were recovered. Sperm was later cryopreserved.
Expressed Gene | MAPT, microtubule associated protein tau, human |
---|---|
Site of Expression |
Allele Name | transgene insertion L1, Lennart Mucke |
---|---|
Allele Type | Transgenic (Inducible, Inserted expressed sequence, Humanized sequence) |
Allele Synonym(s) | hTau-A152T; TRE-hTau-A152T |
Gene Symbol and Name | Tg(tetO-MAPT*A152T)L1Lms, transgene insertion L1, Lennart Mucke |
Gene Synonym(s) | |
Promoter | tetO, tet operator, |
Expressed Gene | MAPT, microtubule associated protein tau, human |
Strain of Origin | C57BL/6 |
Chromosome | UN |
Molecular Note | A transgenic construct containing cDNA of the human MAPT gene encoding the 1N4R isoform, with upstream intronic sequence (from pCI-neo vector) and a Kozak sequence, and downstream bovine growth hormone polyadenylation sequence, all under the control of the tetO, tetracycline-responsive regulatory element (pTRE-Tight). The 1N4R isoform of human MAPT (microtubule associated protein tau) contains an A152T substitution, converting GCC (Ala) at positions 454-456 to ACC (Thr). Founder line C11-1, also known as founder line L1, was established. |
When maintaining a live colony, hemizygous mice may be bred to wildtype siblings, or to C57BL/6J inbred mice (Stock No. 000664). The Donating Investigator has not attempted to make the strain homozygous.
When using the TRE-hTau-A152T L1 mouse strain in a publication, please cite the originating article(s) and include JAX stock #028979 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or non carrier for Tg(tetO-MAPT*A152T)L1Lms |
Frozen Mouse Embryo | C57BL/6-Tg(tetO-MAPT*A152T)L1Lms/J | $2595.00 |
Frozen Mouse Embryo | C57BL/6-Tg(tetO-MAPT*A152T)L1Lms/J | $2595.00 |
Frozen Mouse Embryo | C57BL/6-Tg(tetO-MAPT*A152T)L1Lms/J | $3373.50 |
Frozen Mouse Embryo | C57BL/6-Tg(tetO-MAPT*A152T)L1Lms/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.